相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum neurofilament light chain at time of diagnosis is an independent prognostic factor of survival in amyotrophic lateral sclerosis
E. Thouvenot et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Cerebrospinal fluid neurofilament light chain is elevated in Niemann-Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment response
Dhamidhu Eratne et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Characterization of the visceral and neuronal phenotype of 4L/PS-NA mice modeling Gaucher disease
Victoria Schiffer et al.
PLOS ONE (2020)
Neurofilament light chain as a biomarker in neurological disorders
Lorenzo Gaetani et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
Federico Verde et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease
Oliver Preische et al.
NATURE MEDICINE (2019)
TDP-43 and Cytoskeletal Proteins in ALS
Moritz Oberstadt et al.
MOLECULAR NEUROBIOLOGY (2018)
Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion
Michael Benatar et al.
ANNALS OF NEUROLOGY (2018)
mTh1 driven expression of hTDP-43 results in typical ALS/FTLD neuropathological symptoms
Barbara Scherz et al.
PLOS ONE (2018)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Lenka Novakova et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis
Lenka Novakova et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis
Giulio Disanto et al.
ANNALS OF NEUROLOGY (2017)
Early start of progressive motor deficits in Line 61 α-synuclein transgenic mice
R. Rabl et al.
BMC NEUROSCIENCE (2017)
The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis
Takao Fujisawa et al.
HUMAN MOLECULAR GENETICS (2016)
Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab
Pierre de Flon et al.
NEUROLOGY (2016)
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases (vol 91, pg 56, 2016)
Mehtap Bacioglu et al.
NEURON (2016)
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
Markus Axelsson et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
A Physically-Modified Saline Suppresses Neuronal Apoptosis, Attenuates Tau Phosphorylation and Protects Memory in an Animal Model of Alzheimer's Disease
Khushbu K. Modi et al.
PLOS ONE (2014)
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis
J. Kuhle et al.
ACTA NEUROLOGICA SCANDINAVICA (2013)
Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation
William A. Eimer et al.
MOLECULAR NEURODEGENERATION (2013)
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases
Johanna Gaiottino et al.
PLOS ONE (2013)
Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression
R. Tortelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
A Progressive Mouse Model of Parkinson's Disease: The Thy1-aSyn (Line 61) Mice
Marie-Francoise Chesselet et al.
NEUROTHERAPEUTICS (2012)
Axonal Damage in Relapsing Multiple Sclerosis is Markedly Reduced by Natalizumab
Martin Gunnarsson et al.
ANNALS OF NEUROLOGY (2011)
Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons
Yofre Cabeza-Arvelaiz et al.
MOLECULAR NEURODEGENERATION (2011)
TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration
Hans Wils et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis:: impact of SOD1 genotype
H. Zetterberg et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
Gaucher disease mouse models:: point mutations at the acid β-glucosidase locus combined with low-level prosaposin expression lead to disease variants
Y Sun et al.
JOURNAL OF LIPID RESEARCH (2005)
Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse
J Matsuda et al.
HUMAN MOLECULAR GENETICS (2004)
Elevated neurofilament levels in neurological
N Norgren et al.
BRAIN RESEARCH (2003)
Viable mouse models of acid beta-glucosidase deficiency - The defect in Gaucher disease
YH Xu et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Presymptomatic motor neuron loss and reactive astrocytosis in the sod1 mouse model of amyotrophic lateral sclerosis
SJ Feeney et al.
MUSCLE & NERVE (2001)
分享论文
